Establishing robust cognitive dimensions for characterization and differentiation of patients with Alzheimer's disease, mild cognitive impairment, frontotemporal dementia and depression

International Journal of Geriatric Psychiatry

Volumn 29, Issue 6, 2014, Pages 624-634

  Beck, Irene R ^a   Schmid, Nicole S ^a   Berres, Manfred ^b   Monsch, Andreas U ^a  

^a Felix Platter Spital   (Switzerland)

^b UNIVERSITY OF APPLIED SCIENCES KOBLENZ   (Germany)

Author keywords

cognitive dimensions; cognitive profiles; dementia; factor analysis

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; DISEASE COURSE; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TEST; SCORING SYSTEM; COGNITION; DEPRESSIVE DISORDER; DIFFERENTIAL DIAGNOSIS; FACTOR ANALYSIS; MIDDLE AGED; PSYCHOLOGY; RECEIVER OPERATING CHARACTERISTIC; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COGNITION; DEPRESSIVE DISORDER; DIAGNOSIS, DIFFERENTIAL; FACTOR ANALYSIS, STATISTICAL; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMANS; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; ROC CURVE;

EID: 84899938939     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.4045     Document Type: Article

References (43)

1. Albert MS, DeKosky ST, Dickson D, et al,. 2011. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging and Alzheimer's Association Workgroup. Alzheimers Dement 7: 270-279.
2. American Psychiatric Association. 1994. DSM IV: Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Press: Washington, DC.
3. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J,. 1961. An inventory for measuring depression. Arch Gen Psychiatry 4: 561-571.
4. Berres M, Monsch AU, Bernasconi F, Thalmann B, Stähelin HB,. 2000. Normal ranges of neuropsychological tests for the diagnosis of Alzheimer's disease. Stud Health Tech Informat 77: 195-199.
5. Berres M, Zehnder A, Bläsi S, Monsch AU,. 2008. Evaluation of diagnostic scores with adjustment for covariates. Stat Med 27: 1777-1790.
6. Chapman RM, Mapstone M, McCrary JW, et al,. 2010a. Cognitive dimensions in Alzheimer's disease, mild cognitive impairment, and normal elderly: developing a common metric. Open Geriatr Med J 3: 1-10.
7. Chapman RM, Mapstone M, Porsteinsson AP, et al,. 2010b. Diagnosis of Alzheimer's disease using neuropsychological testing improved by multivariate analyses. J Clin Exp Neuropsychol 32: 793-808.
8. Christensen H, Griffiths K, MacKinnon A, Jacomb P,. 1997. A quantitative review of cognitive deficits in depression and Alzheimer-type dementia. J Int Neuropsychol Soc 3: 631-651.
9. De Jager CA, Hogervorst E, Combrinck M, Budge MM,. 2003. Sensitivity and specificity of neuropsychological tests for mild cognitive impairment, vascular cognitive impairment and Alzheimer's disease. Psychol Med 33: 1039-1050.
10. Delis DC, Kramer JH, Kaplan E, Ober BA,. 1987. California Verbal Learning Test: Adult Version. The Psychological Corporation: San Antonio, TX.
11. Dowling NM, Hermann B, La Rue A, Sager MA,. 2010. Latent structure and factorial invariance of a neuropsychological test battery for the study of preclinical Alzheimer's disease. Neuropsychology 24: 742-756.
12. Dubois B, Feldman HH, Jacova C, et al,. 2007. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 26: 734-746.
13. Ehrensperger MM, Berres M, Taylor KI, Monsch AU,. 2010. Early detection of Alzheimer's disease with a total score of the German CERAD. J Int Neuropsychol Soc 16: 910-920.
14. Folstein MF, Folstein SE, McHugh PR,. 1975. "Mini-mental state"-a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198.
15. Gianotti G, Marra C,. 1994. Some aspects of memory disorders clearly distinguish dementia of the Alzheimer's type from depressive pseudo-dementia. J Clin Exp Neuropsychol 16: 65-78.
16. Harman HH,. 1976. Modern Factor Analysis (3rd edn). University of Chicago: Chicago.
17. Harrison J, Minassian SL, Jenkins L, et al,. 2007. A neuropsychological test battery for use in Alzheimer disease clinical trials. Arch Neurol 64: 1323-1329.
18. Isaacs B, Kennie AT,. 1973. The set test as an aid to the detection of dementia in old people. Brit J Psychiat 23: 467-470.
19. Kaplan E, Goodglass H, Weintraub S,. 1983. Boston Naming Test. Lea & Febiger: Philadelphia.
20. Künig G, Jäger M, Stief V, et al,. 2006. The impact of the CERAD-NP on diagnosis of cognitive deficiencies in late onset depression and Alzheimer's disease. Int J Geriatr Psychiatry 21: 911-916.
21. Lambon Ralph MA, Patterson K, Graham N, Dawson K, Hodges JR,. 2003. Homogeneity and heterogeneity in mild cognitive impairment and Alzheimer's disease a cross-sectional and longitudinal study of 55 cases. Brain 126: 2350-2363.
22. Lannfelt L, Blennow K, Zetterberg H, et al,. 2008. Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease a phase IIa, double-blind, randomized, placebo-controlled trial. Lancet Neurol 7: 779-786.
23. Levy JA, Chelune GJ,. 2007. Cognitive-behavioral profiles of neurodegenerative dementias: beyond Alzheimer's disease. J Geriatr Psych Neur 20: 227-238.
24. McKhann G, Drachman D, Folstein M, et al,. 1984. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 34: 939-944.
25. McKhann GM, Knopman DS, Chertkow H, et al,. 2011. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging and the Alzheimer's Association Workgroup. Alzheimers Dement 7: 263-269.
26. Monsch AU, Thalmann B, Schneitter M, et al,. 2000. The Basel study on the elderly's search for preclinical cognitive markers of Alzheimer's disease. Neurobiol Aging 21: 31.
27. Morris JC, Mohs RC, Rogers H, Fillenbaum G, Heyman A,. 1988. Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. Psychopharmacol Bull 24: 641-652.
28. Neary D, Snowden JS, Gustafson L, et al,. 1998. Frontotemporal lobar degeneration a consensus on clinical diagnostic criteria. Neurology 51: 1546-1554.
29. Ownby RL, Loewenstein DA, Schram L, Acevedo A,. 2004. Assessing the cognitive abilities that differentiate patients with Alzheimer's disease from normals: single and multiple factor models. Int J Geriatr Psychiatry 19: 232-242.
30. Perry RJ, Hodges JR,. 2000. Differentiating frontal and temporal variant frontotemporal dementia from Alzheimer's disease. Neurology 54: 2277-2284.
31. Rascovsky K, Salmon DP, Hansen LA, Thal LJ, Galasko D,. 2007. Disparate phonemic and semantic fluency deficits in autopsy-confirmed frontotemporal dementia and Alzheimer's disease. Neuropsychology 21: 20-30.
32. Regard M, Strauss E, Knapp P,. 1982. Children's production on verbal and nonverbal fluency tasks. Percept Mot Skill 55: 839-844.
33. Rey A,. 1941. L'examen psychologique dans les cas d'encephalopathie traumatique. Arch Psychol 28: 286-340.
34. Romàn GC, Tatemichi TK, Erkinjuntti T, et al,. 1993. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43: 250-260.
35. Rosen WG, Mohs RC, Davis KL,. 1984. A new rating scale for Alzheimer's disease. Am J Psychiat 141: 1356-1364.
36. Sheikh JI, Yesavage JA,. 1986. Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. Clin Gerontol 5: 165-173.
37. Siedlecki KL, Honig LS, Stern Y,. 2008. Exploring the structure of a neuropsychological battery across healthy elders and those with questionable dementia and Alzheimer's disease. Neuropsychology 22: 400-411.
38. Spreen O, Benton AL,. 1977. Neurosensory Centre Comprehensive Examination for Aphasia. University of Victoria: Victoria.
39. Spreen O, Strauss E,. 1991. A Compendium of Neuropsychological Tests (2nd edn). Oxford University Press: New York, NY.
40. Stroop JR,. 1935. Studies of interference in serial verbal reaction. J Clin Exp Neuropsychol 18: 643-662.
41. Vellas B, Black R, Thal LJ, et al,. 2009. Long-term follow-up of patients immunized with AN1792: reduced functional decline in antibody responders. Curr Alzheimer Res 6: 144-151.
42. Wechsler D,. 1987. Wechsler Memory Scale-Revised. Psychological Corporation: New York.
43. Winblad B, Palmer K, Kivipelto M, et al,. 2004. Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on mild cognitive impairment. J Intern Med 256: 240-246.